Lexaria Bioscience Corp. has been granted two new patents from the United States Patent and Trademark Office for the use of its DehydraTECH™ enhanced processing technology in treating epilepsy. The new patents, which expire in 2043, strengthen Lexaria's intellectual property portfolio and its ability to commercialize DehydraTECH™ for this indication.
announce that we have been granted two new patents from the United States Patent and Trademark Office for the use of DehydraTECH™ enhanced processing technology related to the treatment of epilepsy.
“We are thrilled to have received broadened claims related to our proprietary DehydraTECH™ technology for the treatment of epilepsy,” said Rich Christopher, CEO of Lexaria. “Each of our patent awards enhances our ability to reach commercial criticality while providing enhanced value to our potential pharmaceutical partners and, ultimately, to patients.
periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part.
Premier Doug Ford said the province would ban any Chinese state-owned enterprise from buying or taking equity in any government-funded asset.CATL and Lopal restart China lithium refinery despite price routEU says it would react to US steel tariffs, awaits details Trump said on Sunday that he would introduce new 25% tariffs on all steel and aluminum imports into the US.MacMillan, who started out as a prospector in the ’30s, became the central figure in one of Canada's most commented mining scandals.Japanese Prime Minister Shigeru Ishiba said on Sunday that there are legal questions regarding the distinction between acquisition and investment.
PATENTS DEHYDTECH EPILEPSY DRUG DELIVERY LEXARIA BIOSCIENCE
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lexaria Advances Human Pilot Study #3 with Addition of DehydraTECH-tirzepatide Arm and Positive Regulatory UpdatesLexaria Bioscience Corp. announces progress updates for its Human Pilot Study 3, including the addition of a new arm to evaluate its DehydraTECH-tirzepatide formulation, and the receipt of HREC approval for all study arms across participating clinical sites.
Read more »
KAUST Bioscience Program Seeks Researchers to Advance Human and Animal HealthThe KAUST Bioscience Program is launching a major initiative to bolster research in human and animal health, seeking ambitious candidates at the Assistant Professor level (Associate and Full Professor considered) with a strong track record in publications and a passion for pioneering innovative, technology-driven research. The program emphasizes Infection Biology, Microbiomics, and Epidemiological Disease Modelling, utilizing experimental and Omics methodologies to investigate host-pathogen interactions, immunology, and the mechanisms underlying host resistance to microbes and viruses. Candidates should also have expertise in microbiome-based therapeutic strategies, infectious disease modeling, and vaccine development, with a focus on global and Middle Eastern health challenges.
Read more »
KAUST Bioscience Program Seeks Ambitious Researchers in Human and Animal HealthThe Bioscience Program at KAUST is launching a major initiative to advance research in human and animal health. They are specifically looking for Assistant Professors (with consideration for Associate and Full Professors) with a strong background in Biological Sciences and a proven track record of publications in top-tier journals. Successful candidates will lead innovative, technology-driven research in Infection Biology, Microbiomics, and Epidemiological Disease Modeling.
Read more »
Man Charged in Fatal Houston Shooting Granted $1 Million BondA man accused of murder and aggravated assault in a deadly road rage shooting in southwest Houston has been granted a $1 million bond. Authorities used surveillance video and license plate readers to connect the suspect to the 2024 incident that killed 23-year-old Jadrian Edwards.
Read more »
A New Zealand mountain is granted personhood, recognizing it as sacred for MāoriA mountain in New Zealand considered an ancestor by Indigenous people has been recognized as a legal person after a new law granted it all the rights and responsibilities of a human being.
Read more »
New Zealand Mountain Granted PersonhoodMount Taranaki, a sacred mountain for Māori people in New Zealand, has been granted legal personhood, recognizing it as an ancestor and ensuring its rights and well-being are protected. The recognition fulfills a long-standing agreement with Māori tribes for redress of land injustices committed during colonization.
Read more »